COURTNEY WATERS: Open Payments
NPI 1811508435 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 96 payments from 22 companies in 2025. Trend: 2023 $1,256 · 2024 $865 · 2025 $1,627
Food & beverage: $1,627
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $362 |
| Lilly USA, LLC | 18 | $226 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $166 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Grifols USA, LLC | 4 | $81 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Novo Nordisk Inc | 4 | $67 |
| PFIZER INC. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
Products named: VRAYLAR, MOUNJARO, JARDIANCE, CAPLYTA, QULIPTA, BREZTRI, Prolastin-C Liquid, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
